BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiore AE, Moroney JF, Farley MM, Harrison LH, Patterson JE, Jorgensen JH, Cetron M, Kolczak MS, Breiman RF, Schuchat A. Clinical Outcomes of Meningitis Caused by Streptococcus pneumoniae in the Era of Antibiotic Resistance. Clinical Infectious Diseases 2000;30:71-7. [DOI: 10.1086/313606] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kwak EJ, Mcclure J, Mcgeer A, Lee BC. Exploring the Pathogenesis of Necrotizing Fasciitis Due to Streptococcus pneumoniae. Scandinavian Journal of Infectious Diseases 2009;34:639-44. [DOI: 10.1080/00365540210147985] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
2 Leibovitz E. The effect of vaccination on Streptococcus pneumoniae resistance. Curr Infect Dis Rep 2008;10:182-91. [DOI: 10.1007/s11908-008-0031-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
3 Rodriguez-Cerrato V, Ghaffar F, Saavedra J, Michelow IC, Hardy RD, Iglehart J, Olsen K, McCracken GH Jr. BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 2001;45:3098-103. [PMID: 11600362 DOI: 10.1128/AAC.45.11.3098-3103.2001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Jackson LA, Neuzil KM. Pneumococcal polysaccharide vaccines. Vaccines. Elsevier; 2008. pp. 569-604. [DOI: 10.1016/b978-1-4160-3611-1.50028-3] [Cited by in Crossref: 10] [Article Influence: 0.7] [Reference Citation Analysis]
5 Choi S, Chung J, Kim B, Kwak YG, Kim TH, Lee EJ, Choo EJ, Jeon M, Lee MS, Bae I, Lee S, Song EH, Jun J, Kim M, Kim S, Lee S, Kim YS, Woo JH, Choi S. Clinical implication of extended-spectrum cephalosporin nonsusceptibility in Streptococcus pneumoniae meningitis. Eur J Clin Microbiol Infect Dis 2012;31:3029-34. [DOI: 10.1007/s10096-012-1657-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Auburtin M, Porcher R, Bruneel F, Scanvic A, Trouillet JL, Bédos JP, Régnier B, Wolff M. Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am J Respir Crit Care Med 2002;165:713-7. [PMID: 11874820 DOI: 10.1164/ajrccm.165.5.2105110] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 4.6] [Reference Citation Analysis]
7 Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther. 2008;6:751-763. [PMID: 18847410 DOI: 10.1586/14787210.6.5.751] [Cited by in Crossref: 184] [Cited by in F6Publishing: 177] [Article Influence: 13.1] [Reference Citation Analysis]
8 Soult Rubio J, Rangel Pineda C, Muñoz Sáez M, Parrilla Parrilla J, Díaz Fernández F, López Castilla J, Tovaruela Santos A. Meningitis neumocócica: características epidemiológicas, clínicas y bacteriológicas. Anales de Pediatría 2001;55:315-20. [DOI: 10.1016/s1695-4033(01)77692-8] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
9 Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect 2010;61:114-24. [PMID: 20433866 DOI: 10.1016/j.jinf.2010.04.008] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
10 Sarlangue J, Castella C, Lehours P. [First and second line antibiotic therapy for bacterial meningitis in infants and children]. Med Mal Infect 2009;39:521-30. [PMID: 19409744 DOI: 10.1016/j.medmal.2009.02.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
11 Thabet F, Tilouche S, Tabarki B, Amri F, Guediche M, Sfar M, Harbi A, Yacoub M, Essoussi A. Mortalité par méningites à pneumocoque chez l'enfant. Facteurs pronostiques à propos d'une série de 73 observations. Archives de Pédiatrie 2007;14:334-7. [DOI: 10.1016/j.arcped.2006.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
12 Tan TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Curr Opin Infect Dis 2003;16:271-7. [PMID: 12821820 DOI: 10.1097/00001432-200306000-00015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
13 Olarte L, Barson WJ, Barson RM, Lin PL, Romero JR, Tan TQ, Givner LB, Bradley JS, Hoffman JA, Hultén KG, Mason EO, Kaplan SL. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children. Clin Infect Dis 2015;61:767-75. [PMID: 25972022 DOI: 10.1093/cid/civ368] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 11.7] [Reference Citation Analysis]
14 Scheifele D, Halperin S, Pelletier L, Talbot J, Lovgren M, Vaudry W, Jadavji T, Law B, Macdonald N, Gold R, Wang E, Mills E, Lebel M, Déry P, Morris R. Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998. Can J Infect Dis 2001;12:241-6. [PMID: 18159346 DOI: 10.1155/2001/984958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
15 von Mollendorf C, Cohen C, de Gouveia L, Quan V, Meiring S, Feldman C, Klugman KP, von Gottberg A. Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. Antimicrob Agents Chemother 2014;58:3293-305. [PMID: 24687499 DOI: 10.1128/AAC.02580-13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
16 McGowan JE Jr. Increasing threat of Gram-positive bacterial infections in the intensive care unit setting. Crit Care Med 2001;29:N69-74. [PMID: 11345092 DOI: 10.1097/00003246-200104001-00003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
17 Moroney JF, Fiore AE, Harrison LH, Patterson JE, Farley MM, Jorgensen JH, Phelan M, Facklam RR, Cetron MS, Breiman RF, Kolczak M, Schuchat A. Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance. Clin Infect Dis 2001;33:797-805. [PMID: 11512085 DOI: 10.1086/322623] [Cited by in Crossref: 103] [Cited by in F6Publishing: 79] [Article Influence: 4.9] [Reference Citation Analysis]
18 Feigin RD, Cutrer WB. BACTERIAL MENINGITIS BEYOND THE NEONATAL PERIOD. Feigin and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier; 2009. pp. 439-71. [DOI: 10.1016/b978-1-4160-4044-6.50042-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Tsai M, Chen S, Hsu C, Yan D, Yen M, Chiu C, Huang Y, Lin T. Pneumococcal Meningitis in Taiwanese Children: Emphasis on Clinical Outcomes and Prognostic Factors. Journal of Tropical Pediatrics 2008;54:390-4. [DOI: 10.1093/tropej/fmn046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Kaplan SL. Management of pneumococcal meningitis: . The Pediatric Infectious Disease Journal 2002;21:589-91. [DOI: 10.1097/00006454-200206000-00034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
21 Fisk BA, Jackson WL. Outcomes following pneumococcal meningitis: Room for improvement remains expansive*: . Critical Care Medicine 2006;34:2853-5. [DOI: 10.1097/01.ccm.0000240235.31535.af] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Gessler P, Martin F, Suter D, Berger C. Invasive pneumococcal disease in children prior to implementation of the conjugate vaccine in the Zurich region, Switzerland. Acta Paediatr 2010;99:1005-10. [PMID: 20219035 DOI: 10.1111/j.1651-2227.2010.01748.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Wasier A, Chevret L, Essouri S, Durand P, Chevret S, Devictor D. Pneumococcal meningitis in a pediatric intensive care unit: Prognostic factors in a series of 49 children: . Pediatric Critical Care Medicine 2005;6:568-72. [DOI: 10.1097/01.pcc.0000170611.85012.01] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
24 Tunkel AR, Scheld WM. Treatment of bacterial meningitis. Curr Infect Dis Rep 2002;4:7-16. [DOI: 10.1007/s11908-002-0062-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
25 Buckingham SC, McCullers JA, Luján-Zilbermann J, Knapp KM, Orman KL, English BK. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J 2001;20:837-43. [PMID: 11734760 DOI: 10.1097/00006454-200109000-00003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
26 Hoffman O, Weber RJ. Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord 2009;2:1-7. [PMID: 21180625 DOI: 10.1177/1756285609337975] [Cited by in Crossref: 73] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
27 Clarke P, Murchan S, Smyth E, Humphreys H. Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clinical Microbiology and Infection 2004;10:657-9. [DOI: 10.1111/j.1469-0691.2004.00894.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
28 Stahl JP. [Treatment of community acquired bacterial meningitis, after microbiological identification]. Med Mal Infect 2009;39:513-20. [PMID: 19394177 DOI: 10.1016/j.medmal.2009.02.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
29 Cunha BA. ANTIBIOTIC RESISTANCE. Medical Clinics of North America 2000;84:1407-29. [DOI: 10.1016/s0025-7125(05)70295-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Klepser ME, Klepser DG, Ernst EJ, Brooks J, Diekema DJ, Mozaffari E, Hendrickson J, Doern GV. Health Care Resource Utilization Associated with Treatment of Penicillin-Susceptible and -Nonsusceptible Isolates of Streptococcus pneumoniae. Pharmacotherapy 2003;23:349-59. [DOI: 10.1592/phco.23.3.349.32105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
31 Bolton-maggs PH. The diagnosis and management of hereditary spherocytosis. Best Practice & Research Clinical Haematology 2000;13:327-42. [DOI: 10.1053/beha.2000.0081] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
32 Kellner JD, Scheifele DW, Halperin SA, Lebel MH, Moore D, Le Saux N, Ford-Jones EL, Law B, Vaudry W; Canadian Paediatric Society/Centre for Infectious Disease Prevention and Control Immunization Monitoring Program. Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J 2002;21:903-10. [PMID: 12394810 DOI: 10.1097/00006454-200210000-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
33 Santos LC, Simões J, Severo M, Vazquez J, Lecour H. Bacterial Meningitis in an Urban Area: Etiologic Study and Prognostic Factors. Infection 2007;35:406-13. [DOI: 10.1007/s15010-007-7035-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
34 Floret D. Méningite à pneumocoque et résistance bactérienne. Archives de Pédiatrie 2002;9:1166-72. [DOI: 10.1016/s0929-693x(02)00078-7] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
35 Lovera D, Arbo A. Risk factors for mortality in Paraguayan children with pneumococcal bacterial meningitis. Trop Med Int Health 2005;10:1235-41. [PMID: 16359403 DOI: 10.1111/j.1365-3156.2005.01513.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
36 Morrow A, De Wals P, Petit G, Guay M, Erickson LJ. The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine. Can J Infect Dis Med Microbiol 2007;18:121-7. [PMID: 18923713 DOI: 10.1155/2007/713576] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
37 Nyasulu P, Cohen C, De Gouveia L, Feldman C, Klugman KP, von Gottberg A; Group for Enteric, Respiratory and Meningeal Diseases Surveillance in South Africa (GERMS-SA). Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005. Pediatr Infect Dis J 2011;30:1075-80. [PMID: 21799459 DOI: 10.1097/INF.0b013e31822cca05] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
38 Dubos F. Stratégie de prise en charge (diagnostic, surveillance, suivi) d’une méningite présumée bactérienne de l’enfant. Médecine et Maladies Infectieuses 2009;39:615-28. [DOI: 10.1016/j.medmal.2009.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Aronin SI, Quagliarello VJ. New perspectives on pneumococcal meningitis. Hosp Pract (1995) 2001;36:43-6, 49-50, 51. [PMID: 11220360 DOI: 10.3810/hp.2001.02.228] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
40 Martínez E, Miró JM, Almirante B, Aguado JM, Fernandez‐viladrich P, Fernandez‐guerrero ML, Villanueva JL, Dronda F, Moreno‐torrico A, Montejo M, Llinares P, Gatell JM; Spanish Pneumococcal Endocarditis Study Group. Effect of Penicillin Resistance of Streptococcus pneumoniae on the Presentation, Prognosis, and Treatment of Pneumococcal Endocarditis in Adults. CLIN INFECT DIS 2002;35:130-9. [DOI: 10.1086/341024] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
41 Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42 Suppl 2:S82-S89. [PMID: 16355321 DOI: 10.1086/499406] [Cited by in Crossref: 664] [Cited by in F6Publishing: 571] [Article Influence: 41.5] [Reference Citation Analysis]
42 Sáez-Llorens X, McCoig C, Feris JM, Vargas SL, Klugman KP, Hussey GD, Frenck RW, Falleiros-Carvalho LH, Arguedas AG, Bradley J, Arrieta AC, Wald ER, Pancorbo S, McCracken GH Jr, Marques SR; Trovan menigitis Study Group. Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin. Pediatr Infect Dis J 2002;21:14-22. [PMID: 11791092 DOI: 10.1097/00006454-200201000-00004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
43 Kaplan SL, Mason EO. Mechanisms of Pneumococcal Antibiotic Resistance and Treatment of Pneumococcal Infections in 2002. Pediatr Ann 2002;31:250-60. [DOI: 10.3928/0090-4481-20020401-09] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
44 Østergaard C, Konradsen HB, Samuelsson S. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. BMC Infect Dis 2005;5:93. [PMID: 16253143 DOI: 10.1186/1471-2334-5-93] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 4.2] [Reference Citation Analysis]
45 Gouveia EL, Reis JN, Flannery B, Cordeiro SM, Lima JB, Pinheiro RM, Salgado K, Mascarenhas AV, Carvalho MG, Beall BW, Reis MG, Ko AI. Clinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study. BMC Infect Dis 2011;11:323. [PMID: 22103652 DOI: 10.1186/1471-2334-11-323] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
46 Stratton CW. Antimicrobial resistance in respiratory tract pathogens. Expert Rev Anti Infect Ther 2004;2:641-7. [PMID: 15482226 DOI: 10.1586/14787210.2.4.641] [Reference Citation Analysis]
47 Mohan PV, Heath PT. Pneumococcal disease in childhood. Hosp Med 2001;62:406-9. [PMID: 11480127 DOI: 10.12968/hosp.2001.62.7.1609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
48 Chomarat M, Fredenucci I, Barbé G, Boucaud-maitre Y, Boyer M, Carricajo A, Célard M, Clergeau P, Croizé J, Delubac F, Fèvre D, Fuhrmann C, Gilles Y, Gravagna B, Helfre M, Letouzey M, Lelièvre H, Mandjee A, Marchal M, Marthelet P, Meley R, Perrier-gros-claude J, Bercion R, Reverdy M, Ros A, Roure C, Sabot O, Smati S, Thierry J, Tixier A, Tous J, Verger P, Zaoui E. Observatoire Rhône-Alpes du pneumocoque en 1999 : 35 cas de méningites. Pathologie Biologie 2002;50:595-8. [DOI: 10.1016/s0369-8114(02)00356-5] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006;34:2758-65. [PMID: 16915106 DOI: 10.1097/01.CCM.0000239434.26669.65] [Cited by in Crossref: 172] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
50 Grandgirard D, Burri M, Agyeman P, Leib SL. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother 2012;56:4289-95. [PMID: 22644021 DOI: 10.1128/AAC.00674-12] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
51 Yoo IY, Kang OK, Lee MK, Kim YJ, Cho SY, Huh K, Kang CI, Chung DR, Peck KR, Huh HJ, Lee NY. Comparison of 16S Ribosomal RNA Targeted Sequencing and Culture for Bacterial Identification in Normally Sterile Body Fluid Samples: Report of a 10-Year Clinical Laboratory Review. Ann Lab Med 2020;40:63-7. [PMID: 31432641 DOI: 10.3343/alm.2020.40.1.63] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chen S, Yen MH, Chiu C, Yan D, Hsu C, Lin T. Clinical observation of meningitis caused by penicillin-susceptible and -non-susceptible Streptococcus pneumoniae in Taiwanese children. Annals of Tropical Paediatrics 2013;26:181-5. [DOI: 10.1179/146532806x120264] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]